Drawing for MEDOC

USPTO serial 86375776

MEDOC

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
PARADEWELAI, BENJI YUEN
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with MEDOC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Tonics of medicines, namely, medicinal tea, effervescent tablet, chewable tablet or chewing gum for medical purposes to prevent prostatitis and benign prostatic hyperplasia; Medicines for human purposes, namely, medicines for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Pharmaceutical preparations for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Drugs for medical purposes for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Antiseptics; Sterilizing preparations; Air purifying preparations; Preparations for destroying noxious animals; Biocides; Incontinence pads; Surgical dressings; Aseptic cotton; Medicines to prevent prostatitis and benign prostatic hyperplasia in the form of teasABANDONED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 2, 2015MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
Dec 2, 2015ABN4ABANDONMENT - AFTER INTER PARTES DECISION
Dec 2, 2015OP.TOPPOSITION TERMINATED NO. 999999
Dec 2, 2015OP.SOPPOSITION SUSTAINED NO. 999999
Aug 26, 2015OP.IOPPOSITION INSTITUTED NO. 999999
Aug 26, 2015OPPFOPPOSITION PAPERS RECEIVED AT TTAB
Jul 28, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 28, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 8, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 21, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 18, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jun 18, 2015XAECEXAMINER'S AMENDMENT ENTERED
Jun 18, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 18, 2015GNEAEXAMINERS AMENDMENT E-MAILED
Jun 18, 2015CNEAEXAMINERS AMENDMENT -WRITTEN
May 28, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 28, 2015CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 28, 2015ALIEASSIGNED TO LIE
May 21, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 21, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 4, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 9, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 9, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 9, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 9, 2014DOCKASSIGNED TO EXAMINER
Sep 9, 2014MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 8, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 28, 2014NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance